Initial dose with booster in 2 to 3 weeks, complete series 2 to 4 weeks before expected anthrax exposure.

Do not vaccinate horses undergoing antibiotic therapy.

Use entire contents when first opened and burn container and any unused vaccine.

Placing the horse in a dark stall for 10 days of rest.

Local tissue reaction suspected; inject under mane.

Not used in mature non-breeding horses.

See Table II for broodmares.

Do not stress horses recently vaccinated for Venezuelan encephalomyelitis.

Vaccination for Venezuelan encephalomyelitis may limit exportation.

Horses can have a transient viremia with Venezuelan encephalomyletis.

Annual for breeding stallions.

Do not vaccinate 2 to 3 weeks before a stressful event.

Some horses have a brief fever, loss of appetite, and depression after vaccination.

Local tissue reaction may occur at injection site.

Only vaccine approved to be given subcutaneously; most commonly given in the muscle.

Local tissue reaction may result if injected subcutaneously.

See Tables II and III for specifications for broodmares and foals.

Use a vaccine that contains EHV-1 and EHV-4 strains.

Annual

Biannual vaccination in horses at risk.

Some horses have post vaccinal reactions or abscesses at IM injection site

Some horses have a severe systemic reaction.

Vaccination does not always prevent infection and clinical signs.

Intra-nasal vaccine appears to offers better protection.

Use in unvaccinated horses or horses of unknown history at time of injury.

Local tissue reaction; anaphylaxis (shock) in some horses.

Give at time of penetrating injury or surgery if the last booster was more than 6 months prior.

Initial dose followed by a second dose in 3-6 weeks with semi-annual or annual boosters.

A third initial dose is ONLY needed if the second booster dose was given after the 6 week period following the first dose. This dose should also be given in the 3-6 weeks period.